BOLD-100 Demonstrates Nanomolar Range Inhibition of Live COVID-19 In Vitro
BOLD-100 Demonstrates Nanomolar Range Inhibition of Live COVID-19 In Vitro
Glympse Bio Secures $46.7 Million to Advance NASH Biosensor Program
Glympse Bio Secures $46.7 Million to Advance NASH Biosensor Program
BOLD-100 Demonstrates Nanomolar Range Inhibition of Live COVID-19 In Vitro
BOLD-100 Demonstrates Nanomolar Range Inhibition of Live COVID-19 In Vitro
IMV Updates Rapid Progress on COVID-19 Vaccine Program
IMV Updates Rapid Progress on COVID-19 Vaccine Program
Blueprint Medicines Announces Global Collaboration with Roche to Develop and Commercialize Pralsetinib for Patients...
Blueprint Medicines Announces Global Collaboration with Roche to Develop and Commercialize Pralsetinib for Patients with RET-Altered Cancers
